MLchartDataset catalogue

Adstiladrin

Term · Oncology and biomedicine · MLC-T-ONC-000278

A drug used to treat adults with a certain type of high-risk bladder cancer that has not invaded the muscle layers of the bladder. It is used in patients whose cancer has not gotten better after treatment with Bacillus Calmette-Guérin (BCG). It is also being studied in the treatment of other types of cancer. Adstiladrin is a weakened adenovirus that carries a copy of the gene for interferon alfa-2b into bladder cancer cells. This may help the body’s immune system recognize the cancer cells and kill them. Adstiladrin is given in a solution that is placed directly into the bladder using a thin tube called a catheter. It is a type of gene therapy. Also called nadofaragene firadenovec.

Table 1. Record
IdentifierMLC-T-ONC-000278
FieldOncology and biomedicine
Synonymsnadofaragene firadenovec
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000278",
  "term": "Adstiladrin",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with a certain type of high-risk bladder cancer that has not invaded the muscle layers of the bladder. It is used in patients whose cancer has not gotten better after treatment with Bacillus Calmette-Guérin (BCG). It is also being studied in the treatment of other types of cancer. Adstiladrin is a weakened adenovirus that carries a copy of the gene for interferon alfa-2b into bladder cancer cells. This may help the body’s immune system recognize the cancer cells and kill them. Adstiladrin is given in a solution that is placed directly into the bladder using a thin tube called a catheter. It is a type of gene therapy. Also called nadofaragene firadenovec.",
  "synonyms": [
    "nadofaragene firadenovec"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/adstiladrin/"
}

Record 484 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.